Success Metrics

Clinical Success Rate
94.4%

Based on 184 completed trials

Completion Rate
94%(184/195)
Active Trials
8(3%)
Results Posted
30%(56 trials)
Terminated
11(5%)

Phase Distribution

Ph phase_2
17
7%
Ph early_phase_1
7
3%
Ph not_applicable
13
6%
Ph phase_3
26
11%
Ph phase_4
34
15%
Ph phase_1
130
57%

Phase Distribution

137

Early Stage

17

Mid Stage

60

Late Stage

Phase Distribution227 total trials
Early Phase 1First-in-human
7(3.1%)
Phase 1Safety & dosage
130(57.3%)
Phase 2Efficacy & side effects
17(7.5%)
Phase 3Large-scale testing
26(11.5%)
Phase 4Post-market surveillance
34(15.0%)
N/ANon-phased studies
13(5.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.2%

184 of 204 finished

Non-Completion Rate

9.8%

20 ended early

Currently Active

8

trials recruiting

Total Trials

229

all time

Status Distribution
Active(11)
Completed(184)
Terminated(20)
Other(14)

Detailed Status

Completed184
unknown14
Terminated11
Withdrawn9
Recruiting8
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
229
Active
8
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (3.1%)
Phase 1130 (57.3%)
Phase 217 (7.5%)
Phase 326 (11.5%)
Phase 434 (15.0%)
N/A13 (5.7%)

Trials by Status

unknown146%
withdrawn94%
not_yet_recruiting31%
terminated115%
completed18480%
recruiting83%

Recent Activity

Clinical Trials (229)

Showing 20 of 229 trialsScroll for more
NCT07850960Phase 4

Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD

Not Yet Recruiting
NCT05646862Phase 3

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Recruiting
NCT07838987Phase 1

A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)

Completed
NCT07665723Phase 1

An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

Recruiting
NCT07824193Phase 1

Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy Participants

Completed
NCT01136317Phase 2

Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

Completed
NCT06383338Phase 1

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

Recruiting
NCT07214662Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

Terminated
NCT07156201Phase 1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

Recruiting
NCT07729293Not Applicable

Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori Infection

Not Yet Recruiting
NCT07037888Phase 4

Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy

Recruiting
NCT06114836Not Applicable

GERD Infant Feeding Therapeutics Trial (GIFT Trial)

Recruiting
NCT06562907Phase 1

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Recruiting
NCT07654049Not Applicable

Study of Teprenone in the Treatment of Glucocorticoid-Induced Drug-Related Gastrointestinal Injury

Not Yet Recruiting
NCT04930991Early Phase 1

High Dose Omeprazole in Patients With Pancreatic Cancer

Terminated
NCT06686628Phase 1

An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

Completed
NCT02783040Phase 1

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Completed
NCT07223671Phase 1

Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

Completed
NCT06378398Early Phase 1

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Completed
NCT07235748Phase 1

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Completed

Drug Details

Intervention Type
DRUG
Total Trials
229